Claude did not invent scorpion antivenom
<figure>
<img alt="A scorpion " data-caption="" data-portal-copyright="Image: Getty Images" data-has-syndication-rights="1" src="https://platform.theverge.com/wp-content/uploads/sites/2/2026/10/gettyimages-182124864.jpg?quality=90&strip=all&crop=0,0,100,100" />
<figcaption>
</figcaption>
</figure>
<p class="wp-block-paragraph">An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom. It couldn't. It came up with some promising starting points, but nothing close to an actual drug, experts tell <em>The Verge</em>. </p>
<p class="wp-block-paragraph">Citrini Research, the firm behind the experiment, admitted that "none of us could claim to know anything about AI as it related to biology." That didn't stop it from trying to make a drug from scratch - or publishing a <a href="https://www.citriniresearch.com/p/citrini-therapeutics">blog post</a> titled "We Wanted to Use Claude to Create a New Drug. Here's What Happened." The account came comple …</p>
<p><a href="https://www.theverge.com/ai-artificial-intelligence/1016443/anthropic-claude-citrini-vibecoding-scorpion-antivenom">Read the full story at The Verge.</a></p>
Read original article ↗
Related Articles
Anthropic launches Claude Duet to automate cross-app tasks
Anthropic has launched a research preview of Claude Duet, an AI agent that connects to email, calendars, and business so
Why AI Can’t Replace Engineering Teams
This article is crossposted from IEEE Spectrum’s careers newsletter. Sign up now to get insider tips, expert advice, and
AAIF reaches 10 projects in its first year, with new contributions from Alibaba, Anthropic, Hugging Face, and OpenAI Sum
OpenAI, Anthropic, and Nvidia had record lobbying quarters
It was a busy summer for AI lobbyists. Anthropic, OpenAI, and Nvidia each had their highest-spending lobbying quarter be